triamcinolone has been researched along with Retinal Diseases in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (17.65) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (47.06) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wolf, MD | 1 |
| Ehlers, JP; Kaiser, PK; McNutt, SA; Srivastava, SK | 1 |
| Kim, KY; Kim, M; Kwak, HW; Yu, SY | 1 |
| Bouhaimed, M; Moussa, M; Othman, IS | 1 |
| Jager, MJ; Missotten, GS; Schlingemann, RO | 1 |
| Ahn, J; Chung, H; Han, JM; Heo, JW; Park, KH; Park, KU; Song, J; Woo, SJ; Yu, HG | 1 |
| Gandorfer, A; Haritoglou, C; Priglinger, S | 1 |
| Anijeet, DR; Bates, RA; Bhagey, J; Hanson, RJ | 1 |
| Liang, Y; Maeda, A; Maeda, T; Saperstein, DA; Yenerel, M | 1 |
| Adewoyin, T; Chong, NV | 1 |
| Cho, GJ; Choi, MY; Choi, WS; Chung, IY; Kang, SS; Kim, YH; Kim, YS; Lee, JH; Park, CH; Roh, GS; Yoo, JM | 1 |
| Braun, B; Hasler, P; Prünte, C; Schneider, U | 1 |
| Bakri, SJ; Diehl, N; Hillemeier, J; Hodge, DO; McCannel, CA; Pulido, JS | 1 |
| Ryan, SJ; Sorgente, N; Sunalp, M; Wiedemann, P | 1 |
| Chang, TS; Hay, D; Mackenzie, PJ | 1 |
| Gutow, GS; Johnston, DT; Wesley, RE | 1 |
| Arena, JE; Chandler, D; Hida, T; Machemer, R | 1 |
1 review(s) available for triamcinolone and Retinal Diseases
| Article | Year |
|---|---|
Intravitreal injection: balancing the risks.
Topics: Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Glucocorticoids; Humans; Injections; Ranibizumab; Retinal Diseases; Treatment Outcome; Triamcinolone; Vitreous Body | 2007 |
16 other study(ies) available for triamcinolone and Retinal Diseases
| Article | Year |
|---|---|
Retinal and choroidal embolization after intranasal injection of triamcinolone acetate.
Topics: Administration, Intranasal; Adolescent; Anti-Inflammatory Agents; Choroid Diseases; Embolism; Humans; Male; Retinal Diseases; Triamcinolone | 2013 |
Contrast-enhanced intraoperative optical coherence tomography.
Topics: Contrast Media; Glucocorticoids; Humans; Imaging, Three-Dimensional; Intraoperative Period; Intravitreal Injections; Reproducibility of Results; Retinal Diseases; Surgery, Computer-Assisted; Tomography, Optical Coherence; Triamcinolone; Vitrectomy | 2013 |
Traumatic chorioretinal folds treated with intra-vitreal triamcinolone injection.
Topics: Adult; Choroid Diseases; Eye Injuries; Glucocorticoids; Humans; Intravitreal Injections; Male; Retinal Diseases; Tomography, Optical Coherence; Triamcinolone | 2013 |
Management of lipid exudates in Coats disease by adjuvant intravitreal triamcinolone: effects and complications.
Topics: Adolescent; Chemotherapy, Adjuvant; Child; Child, Preschool; Exudates and Transudates; Follow-Up Studies; Glucocorticoids; Humans; Infant; Injections, Intraocular; Lipid Metabolism; Macular Edema; Male; Retinal Detachment; Retinal Diseases; Retrospective Studies; Telangiectasis; Treatment Outcome; Triamcinolone; Young Adult | 2010 |
Angiogenesis and vascular endothelial growth factors in intraocular tumors.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Chronic Disease; Eye Neoplasms; Glaucoma, Neovascular; Glucocorticoids; Humans; Inflammation; Injections, Intraocular; Neovascularization, Pathologic; Radiation Injuries; Ranibizumab; Retinal Diseases; Triamcinolone; Vascular Endothelial Growth Factor A | 2010 |
Bilateral same-day intravitreal injections using a single vial and molecular bacterial screening for safety surveillance.
Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Bacteria; Bevacizumab; Drug Administration Schedule; Drug Contamination; Eye Infections, Bacterial; Female; Humans; Intravitreal Injections; Male; Middle Aged; Polymerase Chain Reaction; Ranibizumab; Retinal Diseases; Retrospective Studies; RNA, Ribosomal, 16S; Sensitivity and Specificity; Triamcinolone | 2012 |
[Circulatory disorders of the retina].
Topics: Anti-Inflammatory Agents; Cooperative Behavior; Diabetic Retinopathy; Family Practice; Humans; Injections; Patient Care Team; Retinal Diseases; Retinal Vessels; Risk Factors; Tomography, Optical Coherence; Triamcinolone; Vitreous Body | 2005 |
National survey of the technique of intravitreal triamcinolone injection in the United Kingdom.
Topics: Anterior Chamber; Anti-Inflammatory Agents; Drug Administration Schedule; Health Care Surveys; Humans; Injections; Intraocular Pressure; Medicine; Needles; Ophthalmic Solutions; Paracentesis; Postoperative Care; Retinal Diseases; Specialization; Triamcinolone; United Kingdom; Vitreous Body | 2007 |
Effects of cytotoxic T lymphocyte antigen 4 (CTLA4) signaling and locally applied steroid on retinal dysfunction by recoverin, cancer-associated retinopathy antigen.
Topics: Animals; Antibodies; Antigens, CD; Antigens, Differentiation; Conjunctiva; CTLA-4 Antigen; Female; Glucocorticoids; Injections; Mice; Mice, Inbred BALB C; Peptide Fragments; Recoverin; Retina; Retinal Diseases; Signal Transduction; Triamcinolone | 2006 |
Triamcinolone suppresses retinal vascular pathology via a potent interruption of proinflammatory signal-regulated activation of VEGF during a relative hypoxia.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents; Body Weight; Cytokines; Disease Models, Animal; Encephalitis; Female; Gene Expression Regulation; Hyperoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation Mediators; Neovascularization, Pathologic; Oxidative Stress; Oxygen; Rats; Rats, Sprague-Dawley; Retinal Artery; Retinal Diseases; Signal Transduction; Triamcinolone; Vascular Endothelial Growth Factor A | 2007 |
Combination therapy of PDT and triamcinolone in CNV associated with fundus flavimaculatus.
Topics: Anti-Inflammatory Agents; Choroidal Neovascularization; Combined Modality Therapy; Female; Fundus Oculi; Humans; Middle Aged; Photochemotherapy; Retinal Diseases; Treatment Outcome; Triamcinolone | 2007 |
Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Aptamers, Nucleotide; Bevacizumab; Humans; Injections, Intralesional; Intraocular Pressure; Ocular Hypertension; Ophthalmic Solutions; Paracentesis; Remission, Spontaneous; Retinal Diseases; Triamcinolone | 2009 |
Effects of cytotoxic drugs on proliferative vitreoretinopathy in the rabbit cell injection model.
Topics: Animals; Antineoplastic Agents; Disease Models, Animal; Doxorubicin; Eye Diseases; Female; Fibroblasts; Fluorouracil; Male; Methotrexate; Rabbits; Retinal Detachment; Retinal Diseases; Triamcinolone; Trifluridine; Vitreous Body | 1984 |
Posterior retinal vasculitis associated with multiple sclerosis.
Topics: Adult; Female; Fluorescein Angiography; Glucocorticoids; Humans; Multiple Sclerosis; Retinal Diseases; Retinal Vessels; Triamcinolone; Vasculitis; Visual Acuity | 2002 |
Central retinal artery occlusion.
Topics: Adult; Embolism; Fibroma; Humans; Male; Orbital Neoplasms; Retinal Artery; Retinal Diseases; Triamcinolone | 1987 |
Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations.
Topics: Adrenal Cortex Hormones; Aged; Animals; Betamethasone; Dexamethasone; Eye Diseases; Humans; Injections; Male; Methylprednisolone; Methylprednisolone Acetate; Rabbits; Retinal Diseases; Triamcinolone; Vitreous Body | 1986 |